[artículo]
| Título : |
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder |
| Tipo de documento: |
texto impreso |
| Autores: |
Maria A. Sullivan, Autor ; Adam Bisaga, Autor ; Martina Pavlicova, Autor |
| Fecha de publicación: |
2019 |
| Artículo en la página: |
pp. 129-137 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Inyección de naltrexona, Antagonista opioide, Trastorno de uso de opioides, Naltrexona oral, Retención de tratamiento |
| Resumen: |
The oral formulation of the opioid antagonist naltrexone has shown limited effectiveness for treatment of opioid use disorder due to poor adherence. Long-acting injection naltrexone (XR-naltrexone), administered monthly, circumvents the need for daily pill taking, potentially improving adherence, and has been shown to be superior to placebo in reducing opioid use over 6 months of treatment. |
| Link: |
./index.php?lvl=notice_display&id=20489 |
in The American Journal of Psychiatry > Año 2019 - Vol. 176 - No.2 (Febrero) . - pp. 129-137
|
Añadir el resultado a su cestaA Population-Based Analysis of the Relationship Between Substance Use and Adolescent Cognitive Development en The American Journal of Psychiatry, Año 2019 - Vol. 176 - No.2 (Febrero)
